Cannabisblüten Klenk über den pharmazeutischen Großhandel lieferbar
The traditional company Heinrich Klenk and the market leader in the field of medical cannabis Pedanios are cooperating. From mid-May, the first batch of cannabis flowers Klenk 18/1 with the PZN 13895702 will be available from pharmaceutical wholesalers.
“We already worked very well with Klenk during the tender for German cultivation, which has unfortunately now been stopped,” says Patrick Hoffmann, Managing Director of Pedanios. “Klenk is the medicinal herb specialist in the pharmacy market and was one of our first contacts.” “Expanding the collaboration through our own Klenk products was then just the logical step,” adds Dr. Florian Holzapfel, who founded the Pedanios company together with Hoffmann.
“We welcome the use of cannabis flowers as an alternative or complementary therapy. The name Klenk stands for the highest pharmacopoeia quality from pharmaceutical plants. The cannabis range will be expanded to include further varieties in the next few months,” says Stefan Oehler, Managing Director at Klenk.
Klenk will be the first supplier of cannabis flowers with Klenk 18/1 (PZN 13895702) available through pharmaceutical wholesalers. “Pharmaceutical wholesale has been a strategic partner of Klenk for decades and we want to offer pharmacies and patients the fastest and most uncomplicated access to goods that are in short supply,” says Stefan Oehler. “Klenk as a medicinal herb specialist and Pedanios/Aurora as a cannabis specialist complement each other excellently.”
About Heinrich Klenk GmbH
We are a family-run company with around 100 employees and have been trading plant raw materials internationally for more than 90 years. We procure, analyze and process these for our customers in the pharmaceutical, food and feed industries. We have been the natural partner for pharmacies in the area of medicinal herbs, medicinal and food teas for decades.
About Pedanios GmbH
Pedanios GmbH is an approved pharmaceutical wholesaler and GMP-certified company for the import and distribution of pharmaceuticals. Within the European Union, Pedanios GmbH is the leading importer, exporter and distributor of medical cannabis and has been a 100% subsidiary of Aurora since 2017.
About Aurora Cannabis
Aurora is the leading licensed producer of medical cannabis in Canada. The company now operates two production facilities with approximately 10,000 square meters in Alberta and Quebec. In January 2018, an 80,000 square meter manufacturing facility was licensed at the Edmonton Airport and an additional 150,000 square meter facility was recently announced in Quebec. Once at full capacity, the production facilities are expected to produce over 250,000 kg of cannabis per year.
Aurora is nearing completion of the acquisition of all outstanding shares of CanniMed Therapeutics Inc., Canada's most experienced licensed medical cannabis manufacturer, with annual capital appreciation of over 20,000 kg and Canada's strongest medical cannabis brand.
The company owns 51% of Aurora Nordic, which will build a 100,000 square meter hybrid greenhouse in Odense, Denmark.
Comments